Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases

R. Perret, M. Michal, RA. Carr, V. Velasco, M. Švajdler, M. Karanian, A. Meurgey, S. Paindavoine, I. Soubeyran, JM. Coindre, R. Boidot, C. Charon-Barra, D. Geneste, N. Weingertner, D. Pissaloux, F. Tirode, J. Baud, F. Le Loarer

. 2021 ; 79 (5) : 810-825. [pub] 20210905

Language English Country Great Britain

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22011988

AIMS: Superficial CD34-positive fibroblastic tumor (SCD34FT) and PRDM10-rearranged soft tissue tumor (PRDM10-STT) are rare mesenchymal tumors. These lesions have clinicopathological similarities, but their relationship remains controversial. This study aimed to characterise a series of cases of SCD34FT and PRDM10-STT. METHODS AND RESULTS: Ten lesions each of SCD34FT and PRDM10-STT were studied using immunohistochemistry, array-comparative genomic hybridisation (aCGH), RNA sequencing and exome sequencing. Tumors mainly occurred in young adults, were generally small (< 5 cm) and arose predominantly in the superficial soft tissues of the lower extremities. Follow-up data were available in 15 cases (SCD34FT, n = 7, median 16 months; PRDM10-STT, n = 8, median 14 months), local recurrences occurred in four cases (SCD34FT, two of 10; PRDM10-STT, two of 10), while no distant spread was documented. Morphologically, tumors were relatively well-circumscribed and composed of sheets and fascicles of spindle and pleomorphic cells showing low mitotic activity (< 1/mm2) without necrosis. Other findings included: granular cell change, lipoblast-like cells, ectatic blood vessels with fibrinous material, myxoid stromal changes, metaplastic bone and increased mitotic activity (> 1/mm2). All tumors diffusely expressed CD34, while pan-keratin and desmin were commonly seen focally. SynCAM3 was diffusely expressed in 12 cases (SCD34FT, n = 5; PRDM10-STT, n = 7), independently of fusion status. aCGH profiles were 'flat' (PRDM10-STT, n = 4; SCD34FT, n = 2) and exome sequencing showed no recurrent pathogenic mutations (PRDM10-STT, n = 2; SCD34FT, n = 4). Overall, the only morphological features seen exclusively in PRDM10-STT were myxoid stromal changes (three of 10) and metaplastic bone (two of 10). CONCLUSION: We expand the current knowledge on PRDM10-STT and SCD34FT and provide additional evidence for considering them as overlapping entities.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011988
003      
CZ-PrNML
005      
20220506125930.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/his.14429 $2 doi
035    __
$a (PubMed)34121219
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Perret, Raul $u Department of Biopathology, Institut Bergonié, Bordeaux, France $1 https://orcid.org/0000000326980249
245    10
$a Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases / $c R. Perret, M. Michal, RA. Carr, V. Velasco, M. Švajdler, M. Karanian, A. Meurgey, S. Paindavoine, I. Soubeyran, JM. Coindre, R. Boidot, C. Charon-Barra, D. Geneste, N. Weingertner, D. Pissaloux, F. Tirode, J. Baud, F. Le Loarer
520    9_
$a AIMS: Superficial CD34-positive fibroblastic tumor (SCD34FT) and PRDM10-rearranged soft tissue tumor (PRDM10-STT) are rare mesenchymal tumors. These lesions have clinicopathological similarities, but their relationship remains controversial. This study aimed to characterise a series of cases of SCD34FT and PRDM10-STT. METHODS AND RESULTS: Ten lesions each of SCD34FT and PRDM10-STT were studied using immunohistochemistry, array-comparative genomic hybridisation (aCGH), RNA sequencing and exome sequencing. Tumors mainly occurred in young adults, were generally small (< 5 cm) and arose predominantly in the superficial soft tissues of the lower extremities. Follow-up data were available in 15 cases (SCD34FT, n = 7, median 16 months; PRDM10-STT, n = 8, median 14 months), local recurrences occurred in four cases (SCD34FT, two of 10; PRDM10-STT, two of 10), while no distant spread was documented. Morphologically, tumors were relatively well-circumscribed and composed of sheets and fascicles of spindle and pleomorphic cells showing low mitotic activity (< 1/mm2) without necrosis. Other findings included: granular cell change, lipoblast-like cells, ectatic blood vessels with fibrinous material, myxoid stromal changes, metaplastic bone and increased mitotic activity (> 1/mm2). All tumors diffusely expressed CD34, while pan-keratin and desmin were commonly seen focally. SynCAM3 was diffusely expressed in 12 cases (SCD34FT, n = 5; PRDM10-STT, n = 7), independently of fusion status. aCGH profiles were 'flat' (PRDM10-STT, n = 4; SCD34FT, n = 2) and exome sequencing showed no recurrent pathogenic mutations (PRDM10-STT, n = 2; SCD34FT, n = 4). Overall, the only morphological features seen exclusively in PRDM10-STT were myxoid stromal changes (three of 10) and metaplastic bone (two of 10). CONCLUSION: We expand the current knowledge on PRDM10-STT and SCD34FT and provide additional evidence for considering them as overlapping entities.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a antigeny CD34 $x metabolismus $7 D018952
650    _2
$a nádorové biomarkery $7 D014408
650    12
$a DNA vazebné proteiny $x genetika $x metabolismus $7 D004268
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibroblasty $x patologie $7 D005347
650    _2
$a genová přestavba $7 D015321
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a nádory měkkých tkání $x genetika $x metabolismus $x patologie $7 D012983
650    12
$a transkripční faktory $x genetika $x metabolismus $7 D014157
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
700    1_
$a Michal, Michael $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic $u Department of Pathology and Molecular Genetics, Bioptical Laboratory Ltd, Plzen, Czech Republic
700    1_
$a Carr, Richard A $u Department of Pathology, Warwick Hospital, Warwick, UK
700    1_
$a Velasco, Valérie $u Department of Biopathology, Institut Bergonié, Bordeaux, France
700    1_
$a Švajdler, Marian $u Department of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic $u Department of Pathology and Molecular Genetics, Bioptical Laboratory Ltd, Plzen, Czech Republic
700    1_
$a Karanian, Marie $u Department of Biopathology, Centre Leon Berard, Lyon, France $u Université Lyon, Claude Bernard Lyon 1 University, Lyon, France
700    1_
$a Meurgey, Alexandra $u Department of Biopathology, Centre Leon Berard, Lyon, France
700    1_
$a Paindavoine, Sandrine $u Department of Biopathology, Centre Leon Berard, Lyon, France
700    1_
$a Soubeyran, Isabelle $u Department of Biopathology, Institut Bergonié, Bordeaux, France
700    1_
$a Coindre, Jean-Michel $u Department of Biopathology, Institut Bergonié, Bordeaux, France $u University of Bordeaux, Talence, France
700    1_
$a Boidot, Romain $u Department of Tumor Biology and Pathology, Molecular Biology Unit, Centre Georges-François Leclerc, Dijon, France
700    1_
$a Charon-Barra, Céline $u Department of Tumor Biology and Pathology, Pathology Unit, Centre Georges-François Leclerc, Dijon, France
700    1_
$a Geneste, Damien $u Department of Bioinformatics, Institut Bergonié, Bordeaux, France
700    1_
$a Weingertner, Noelle $u Department of Pathology, Strasbourg Regional University Hospital (Hautepierre Hospital), Strasbourg, France
700    1_
$a Pissaloux, Daniel $u Department of Biopathology, Centre Leon Berard, Lyon, France $u Université Lyon, Claude Bernard Lyon 1 University, Lyon, France
700    1_
$a Tirode, Franck $u Université Lyon, Claude Bernard Lyon 1 University, Lyon, France
700    1_
$a Baud, Jessica $u University of Bordeaux, Talence, France $u INSERM U1218, Action Unit, Bordeaux, France
700    1_
$a Le Loarer, François $u Department of Biopathology, Institut Bergonié, Bordeaux, France $u University of Bordeaux, Talence, France $u INSERM U1218, Action Unit, Bordeaux, France
773    0_
$w MED00002043 $t Histopathology $x 1365-2559 $g Roč. 79, č. 5 (2021), s. 810-825
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34121219 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506125922 $b ABA008
999    __
$a ok $b bmc $g 1789535 $s 1163189
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 79 $c 5 $d 810-825 $e 20210905 $i 1365-2559 $m Histopathology $n Histopathology $x MED00002043
LZP    __
$a Pubmed-20220425
Back

Find record

Citation metrics

Logged in users only

Archiving options